GLP-1受体激动剂心血管保护机制研究进展
Update on the cardiovascular protective effects of glucagon-like peptide-1 receptor agonists
随着胰高血糖素样肽-1( GLP-1)受体激动剂的广泛应用,越来越多的研究表明,此类药物能够通过调节血糖、血脂、血压,并通过抗炎、抗氧化应激等机制,发挥保护心肌、改善心肌梗死和心力衰竭等方面的效应.
更多Along with the wide use of glucagon-like peptide-1 ( GLP-1 ) receptor agonists,evidence has been accumulated that GLP-1 receptor agonists could lead to myocardial protection,improvement of myocardial infarction and heart failure by ways of regulating blood glucose,lipid and blood pressure,anti-inflammation and anti-oxidative stress,etc.
More- 浏览:297
- 被引:0
- 下载:113
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文